R

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

By Robert Busch 3 Videos
8,500 views
August 14, 2023
22 Comments
Login to view comments. Click here to Login

Featured Video

02:17
Novartis Cardiology

Understanding Acquisition and Billing for a Non-Statin Lipid-Lowerin…

Feat. B. Buell

Featured Video

05:11
Novartis Cardiology

Initiating and Monitoring Patients on a Non-Statin Lipid-Lowering Th…

Feat. R. Sugumaran, P. Shah, S. Shugg

Related Content

AUTOPLAY
47:11
Houston Methodist Hospital

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Feat. G. Davis
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
49:21
Physicians Committee for Responsible Medicine

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Feat. T. J. Key
34:49
Scripps Health

Medications for Weight Loss: The New Satiety Hormones

Feat. K. Fujioka
14:22
Scripps Health

Panel Discussion: Hypertension Management and Coronary Calcium Scori…

Feat. D. Cork, C. Mende, A. Robinson
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
23:35
Practical Ways to Achieve Targets in Diabetes Care

Is There a Future for HbA1c? (Moving Towards CGM: GMI and TIR)

Feat. I. Hirsch
37:21
University of Colorado Department of Medicine

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

Feat. R. Johnson
19:24
National Lipid Association

Do Triglycerides Cause Heart Disease?

Feat. I. Goldberg
26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo
12:26
Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

18:46
Houston Methodist Hospital

MAFLD: What Is It?

Feat. D. Victor
15:33
Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

27:24
Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan
11:36
Columbia University Institute of Human Nutrition

Rainbow Lentil Soup: Columbia / IHN Breast Cancer Awareness Culinary…

Feat. O. Weinstein
26:49
Diana Isaacs

Tirzepatide Updates

33:23
Keck School of Medicine of USC

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Feat. M. Goran
26:32
Practical Ways to Achieve Targets in Diabetes Care

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Feat. S. Nissen
28:05
Michael Makover

The Deadly Paradox: Current Practice, Driven by Guidelines, Is Not A…